Table 1.
Study activity | Consent and screening visit (V0)a | Baseline visit (V1)b within 4 weeks of V0 | Program orientation and intervention for 10 weeks begin training within 2 weeks of V1 | Posttest visit (V2)c within 10-14 weeks of the first training session | No-contact period for 12 weeks | Follow-up visit (V3)d within 16-22 weeks of the first training session |
Informed consent | ✓ |
|
|
|
|
|
Inclusion and exclusion criteria | ✓ |
|
|
|
|
|
Demographics | ✓ |
|
|
|
|
|
Medical history | ✓ |
|
|
|
|
|
Medications | ✓ |
|
|
|
|
|
MoCAe | ✓ |
|
|
|
|
|
GDS-SFf | ✓ |
|
|
|
|
|
C-SSRSg, baseline | ✓ |
|
|
|
|
|
MRIh and PETi imaging |
|
✓ |
|
✓ |
|
|
NIH EXAMINERj |
|
✓ |
|
✓ |
|
✓ |
Train-to-task assessments with heart rate variability and pupillometry |
|
✓ |
|
✓ |
|
✓ |
C-SSRS, since last visit |
|
✓ |
|
✓ |
|
✓ |
Medications, since the last visit |
|
✓ |
|
✓ |
|
✓ |
Adverse effects |
|
✓ |
|
✓ |
|
✓ |
Randomization |
|
✓ |
|
|
|
|
Program Orientation |
|
|
✓ |
|
|
|
Computer training |
|
|
✓ |
|
|
|
Weekly phone check-in |
|
|
✓ |
|
|
|
aV0: consent and screening visit.
bV1: baseline visit.
cV2: posttest visit.
dV3: follow-up visit (end of study).
eMoCA: Montreal Cognitive Assessment.
fGDS-SF: Geriatric Depression Scale–Short Form.
gC-SSRS: The Columbia Suicide Severity Rating Scale.
hMRI: magnetic resonance imaging.
iPET: positron-emission tomography.
jNIH EXAMINER: National Institutes of Health Executive Abilities: Measures and Instruments for Neurobehavioral Evaluation and Research.